CYPHERPUNK TECHNOLOGIES INC

CYPH · NASDAQ

Updated at 2026-10-13 14:53:59

$2.76-4.82%
Today's High
$2.81
Today’s Low
$2.70
CYPHERPUNK TECHNOLOGIES INC (CYPH) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$3.01
Previous Close
$2.90
Volume
9.39M
Market Cap
$312.51M
P/E Ratio
--
EPS
$-0.10

Previous Day Range

$2.86$3.23

52-Week Range

$0.39$4.19

Company Overview

Sector
FINANCIAL SERVICES
Industry
Biotechnology
Sub-industry
ASSET MANAGEMENT
Headquarters
47 THORNDIKE STREET, CAMBRIDGE, MA, UNITED STATES, 02141
Country
US
Listing Date
2017-01-24
Fiscal Year End
December
Shares Outstanding
106.46M
CIK
0001509745

Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$209K

Operating Expenses

2026-06-30

$4.68M

2026-03-31

$4.81M

2025-12-31

$5.1M

2025-09-30

$3.16M

Net Income

2026-06-30

$39.38M

2026-03-31

-$77.16M

2025-12-31

$40.2M

2025-09-30

-$3.3M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

-1.58K%

Earnings Per Share

2026-06-30

$-0.03

2026-03-31

$-0.46

2025-12-31

$0.92

2025-09-30

$-0.08

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$4.68M

2026-03-31

-$82.27M

2025-12-31

$45.25M

2025-09-30

-$2.31M

Effective Tax Rate

2026-06-30

4.77%

2026-03-31

6.21%

2025-12-31

11.16%

2025-09-30

-6.51%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations. Trading related derivatives may involve leveraged losses, liquidation, and liquidity risks. Review product rules carefully before trading.